Issue Open Date
|
25-Apr-23
|
Issue Closing Date
|
27-Apr-23
|
Application Money
|
100
|
Allotment Money
|
|
|
Price Band (Rs.)
|
1026-1080
|
Minimum Bid Quantity.
|
13
|
Issue Size (Shares)
|
40058844
|
Market Lot
|
1
|
|
|
Objective :
|
(i) carry out the Offer for Sale of 40,058,844 Equity Shares by the Selling Shareholders aggregating to ? [?] million.(ii) achieve the benefits of listing the Equity Shares on the Stock Exchanges.
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
Offered / Reserved
|
Bid For
|
|
Non-Institutional Investors
|
6008827
|
22822761
|
3.8
|
Qualified Institutional Buyers
|
8011769
|
393834103
|
49.16
|
Retail Individual Investors
|
8011769
|
393834103
|
49.16
|
|
|
|
Business Description
We are India’s fourth largest pharmaceutical company in terms of Domestic Sales and second largest in terms of sales volume for the Financial Year 2022 (Source: IQVIA Dataset, IQVIA TSA MAT March 2022 Dataset for India (For FY20-22)). We are engaged in develop
|
|
Promoter's Holding
|
Total Share Capital
|
316464857
|
Offered to Public
|
40058844
|
Promoter's Holding (Pre-Issue)
|
79
|
Promoter's Holding (Post-Issue)
|
76.5
|
|
More..
|
|
|
|
|
Address
|
208 Okhla Industrial Estate Phase - 111
New Delhi
,
Delhi
,
110020
Phone :
011-46846700
Email :
investors@mankindpharma.com
Website :
www.mankindpharma.com
|
|
Registrar
|
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B Plot 31-32 Gachibowli Financial District Nanakramguda Hyderabad
|
|
Listed at
|
BSE, NSE
|
|
Lead Manager
|
Axis Capital Ltd. IIFL Securities Ltd. Jefferies India Pvt Ltd. JP Morgan India Pvt Ltd Kotak Mahindra Capital Co Ltd
|
|
Promoters
|
Prem Sheetal Family Trust Rajeev Juneja Rajeev Juneja Family Trust Ramesh Juneja Ramesh Juneja Family Trust Sheetal Arora
|
|